CONMED Corp Files 8-K on Financials
Ticker: CNMD · Form: 8-K · Filed: Nov 5, 2025 · CIK: 816956
Sentiment: neutral
Topics: financial-reporting, 8-K, exhibits
Related Tickers: CNMD
TL;DR
CONMED filed an 8-K on Nov 5, 2025, detailing financial results and exhibits.
AI Summary
CONMED Corporation filed an 8-K on November 5, 2025, reporting on its Results of Operations and Financial Condition, and filing Financial Statements and Exhibits. The filing pertains to the period ending November 5, 2025, with the company incorporated in Delaware and headquartered in Largo, Florida.
Why It Matters
This filing provides investors with crucial updates on CONMED Corporation's financial performance and condition, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine filing of financial information and exhibits, not indicating any immediate operational or financial distress.
Key Numbers
- 001-39218 — SEC File Number (Identifies the company's filing with the SEC.)
- 16-0977505 — EIN (Employer Identification Number for tax purposes.)
Key Players & Entities
- CONMED Corporation (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- Largo, FL (location) — Principal executive offices
- November 5, 2025 (date) — Date of report
FAQ
What specific financial statements or exhibits are being filed with this 8-K?
The filing indicates that 'Financial Statements and Exhibits' are being reported, but the specific details of these documents are not provided in the header information.
What is the primary purpose of this 8-K filing for CONMED Corporation?
The primary purpose is to report on 'Results of Operations and Financial Condition' and to file 'Financial Statements and Exhibits' as of November 5, 2025.
When was CONMED Corporation incorporated?
CONMED Corporation was incorporated in Delaware.
What is CONMED Corporation's principal executive office address?
The principal executive offices are located at 11311 Concept Blvd, Largo, FL 33773.
Does this filing indicate any changes in CONMED Corporation's business operations?
The filing is categorized under 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', suggesting a report on existing operations and financial status rather than a change in business operations.
Filing Stats: 498 words · 2 min read · ~2 pages · Grade level 10.9 · Accepted 2025-11-05 16:15:19
Key Financial Figures
- $0.01 — ange on which registered Common Stock, $0.01 par value CNMD NYSE Indicate by check
Filing Documents
- cnmd-20251105.htm (8-K) — 23KB
- cnmdearningsrelease9302025.htm (EX-99.1) — 408KB
- image_0a.jpg (GRAPHIC) — 52KB
- 0000816956-25-000054.txt ( ) — 639KB
- cnmd-20251105.xsd (EX-101.SCH) — 2KB
- cnmd-20251105_lab.xml (EX-101.LAB) — 21KB
- cnmd-20251105_pre.xml (EX-101.PRE) — 12KB
- cnmd-20251105_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition On November 5, 2025, CONMED Corporation issued a press release announcing financial results for the third quarter ended September 30, 2025. A copy of this press release is attached hereto as Exhibit 99.1. The information in this Current Report on Form 8-K that is furnished under "Item 2.02. Results of Operations and Financial Condition" and Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Act of 1934, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits (d) Exhibits The following exhibits are included herewith: Exhibit No. Description of Exhibit 99.1 Press release dated November 5, 2025, issued by CONMED Corporation. 104 Cover Page Interactive Data File (embedded within the Inline XBRL Document). Signature Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: November 5, 2025 CONMED CORPORATION (Registrant) By: /s/ Todd W. Garner Name: Todd W. Garner Title: Executive Vice President, Finance & Chief Financial Officer